Accuracy, potential harm, weight stigma, and commercial influence in short-form social media content on incretin-based therapies for obesity.
- DOI
- 10.3389/fendo.2026.1844311
- Published
- 2026
- Container
- Frontiers in endocrinology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fendo.2026.1844311,
title = {Accuracy, potential harm, weight stigma, and commercial influence in short-form social media content on incretin-based therapies for obesity.},
author = {Yoon YJ and Velazquez A and Parmar SL and Lotfi K and Wong D and Cristancho C and Salim K and Jeon S and Hong S and Shin H and Apovian CM and Kim DW},
year = {2026},
journal = {Frontiers in endocrinology},
doi = {10.3389/fendo.2026.1844311},
url = {https://doi.org/10.3389/fendo.2026.1844311}
}RIS
TY - JOUR TI - Accuracy, potential harm, weight stigma, and commercial influence in short-form social media content on incretin-based therapies for obesity. AU - Yoon YJ AU - Velazquez A AU - Parmar SL AU - Lotfi K AU - Wong D AU - Cristancho C AU - Salim K AU - Jeon S AU - Hong S AU - Shin H AU - Apovian CM AU - Kim DW PY - 2026 JO - Frontiers in endocrinology DO - 10.3389/fendo.2026.1844311 UR - https://doi.org/10.3389/fendo.2026.1844311 ER -
APA
YJ, Y., A, V., SL, P., K, L., D, W., C, C., K, S., S, J., S, H., H, S., CM, A., & DW, K. (2026). Accuracy, potential harm, weight stigma, and commercial influence in short-form social media content on incretin-based therapies for obesity.. Frontiers in endocrinology. https://doi.org/10.3389/fendo.2026.1844311
Source records
- pubmed · retrieved 2026-11-10T13:32:27.857Z